Indian Journal of Vascular and Endovascular Surgery

: 2018  |  Volume : 5  |  Issue : 4  |  Page : 281--282

How to approach a patient with peripheral arterial disease

Kalkunte R Suresh 
 JIVAS, Bengaluru, Karnataka, India

Correspondence Address:
Dr. Kalkunte R Suresh
JIVAS, Bengaluru, Karnataka

How to cite this article:
Suresh KR. How to approach a patient with peripheral arterial disease.Indian J Vasc Endovasc Surg 2018;5:281-282

How to cite this URL:
Suresh KR. How to approach a patient with peripheral arterial disease. Indian J Vasc Endovasc Surg [serial online] 2018 [cited 2020 Aug 8 ];5:281-282
Available from:

Full Text

The excellent CME article by Dr. Velladaruchi and Prof. Sritharan[1] provides a comprehensive review about approach to a patient with peripheral arterial disease (PAD) – which conventionally refers to lower-limb arterial disease. Since this is a significant problem in India, few additional vignettes might underscore the importance of clinical exam in this patient population. CME articles in IJVES are aimed towards junior doctors, especially those in training in specialties other than vascular surgery.

Few facts to be borne in mind as follows:

A third of patients with PAD are asymptomatic. They do not need any further work up apart from good clinical exam and ankle-brachial index (ABI) but need aggressive medical therapy to prevent future systemic cardiovascular events like myocardial infarction, stroke, limb loss etc., since these patients are at a high risk for these rest of their life. Presence of PAD, symptomatic or not, is the leading indicator of systemic atherosclerotic burden and predictor of future cardiovascular eventsClaudicators rarely progress to Chronic Limb Threatening Ischemia (CLTI) –Once the patient develops limb-threatening ischemia (rest pain, wound and gangrene), there are no effective medical therapies, and patients need revascularization as soon as possibleIt is well documented that primary amputation in these patients is more expensive with increased complications than vascular reconstruction in mid and long term. The following diagram illustrates the published data [Figure 1]As indicated in the CME article, the diagnosis of PAD remains completely clinical, and further diagnostics and therapies are dictated by clinical findings as indicated in [Table 1] below.{Figure 1}{Table 1}

At the end of a good clinical examination, which takes about 15 minutes, a clinician should be able to achieve comprehensive diagnostic and management strategies, before subjecting the patient to any further invasive testing or interventions. The five endpoints of clinical examination are as follows:

Reach presumptive diagnosis, grade functional severity of disease – asymptomatic, caludicant – disabling versus non disabling, chronic limb-threatening ischemia, which could also be life threateningDetermine the anatomical level of the diseases such as aortic, aortoiliac, femoral, and distalAssess the present and future systemic risk factors for cardiovascular complicationsDetermine the pathological diagnosis – atherosclerosis, thromboangiitis obliterans, vasculitis etcDetermine the need for noninvasive workup – ABI, duple.

Any further invasive investigation, if required, should be performed only after consultation with vascular specialist, which ideally should be a vascular surgeon.

Claudication is not an “automatic” indication for invasive workup and revascularization. Intermittent claudication should be further defined as follows:

Nondisabling claudication does not interfere with patient's daily lifestyle. The same claudication distance may have different effect depending on patient's lifestyle. For example, a 70-year-old patient walking 200 m may not be disabling. A younger patient, especially manual worker who can walk even 1 km, can be disabling for him/her. However, initial workup remains only Doppler examination and aggressive medical therapy with lifestyle modification (stop smoking, control DM, and foot care) and medical/exercise therapy. Walking distance can be measured on a treadmill (if no cardiac history) and repeated at about 6 weeks to document any improvement. As a rule, nondisabling claudication does not warrant any form of angiogram or interventionDisabling claudication: limitations that affect the quality of life are as follows:

Affects daily living or earning a livelihoodHistory of significant exercise intoleranceReduced function by appropriate quality of life questionnaireReduced treadmill performance in nonspecific leg symptoms.

Note: Only the first is absolute and others are relative.

Initial therapy consists of aggressive medical therapy as outlined. Failure to improve 6 weeks to 3 months would be an indication for further workup and therapy, only after evaluation by a vascular surgeon. Response is upward of 80% in patients with femoral-distal occlusive diseases.

Unfortunately in India, the patients with chronic limb-threatening ischemia (CLTI which will replace critical limb ischemia in the future) are referred late to vascular surgeons though most present early to medical professionals. This contributes significantly to the overall outcome and cost of providing care to these patients.

Late referral results in patient presenting in systemic sepsis with its inherent problemsPatient will need to undergo multiple procedures (wound debridements and revascularization). This comes at a cost of increased morbidity and mortalityThis also lowers the chances of limb salvage in spite of successful revascularizationIncrease in systemic events such as major adverse cardiac events, renal dysfunctions, and others markedly increase patent morbiditySince the patient comes with septic foot/significant wound burden, the healing process is prolongedOverall cost is markedly increased.

Now with increasing availability of well-trained vascular surgeons (whose focus is only on vascular diseases) across the country, good clinical evaluation and early referral will save many limbs and lives.


1Narayanan S, Boologapandian V. How to approach a patient with peripheral arterial disease. Indian J Vasc Endovasc Surg 2018;5:274-80.